ELAN Q4 2025 Earnings — Elanco Animal Health Incorporated Revenue & Financial Results | Market Cap Arena

ELANElanco Animal Health Incorporated

$12B

Q4 2025 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.1B+12.2% YoY

Gross Profit

$450M39.3% margin

Operating Income

$19M1.7% margin

Net Income

-$276M-24.1% margin

EPS (Diluted)

$-0.55

QoQ Revenue Growth

+0.6%

Cash Flow

Operating Cash Flow

$108M

Free Cash Flow

$46M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$13.4B

Total Liabilities

$6.8B

Stockholders' Equity

$6.5B

Cash & Equivalents

$545M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.1B	$1.0B	+12.2%
Gross Profit	$450M	$389M	+15.7%
Operating Income	$19M	$8M	+137.5%
Net Income	-$276M	-$8M	-3350.0%

Revenue Segments

Farm Animal

$640M36%

Pet Health

$489M27%

Cattle

$296M17%

Poultry

$237M13%

Swine

$107M6%

Contract Manufacturing

$15M1%

Geographic Segments

Non-US

$604M53%

UNITED STATES

$540M47%